Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3202595 | Journal of Allergy and Clinical Immunology | 2006 | 4 Pages |
Abstract
Asthma treatment guidelines are intended to relieve symptoms and to prevent complications such as exacerbations, airway remodeling, and death. The existing recommendations are based on a combination of evidence and expert opinion. Recent data raise questions about the need for chronic controller therapy for those patients at the very low end of the asthma-severity continuum. Although these data are not sufficient to warrant a change in guidelines, the new information points out the need for large, long-term studies on the treatment of mild persistent asthma, with an emphasis on exacerbations, remodeling, and the relationship between these outcomes and markers of asthma control.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stephen C. Lazarus,